KOSDAQ - Delayed Quote KRW

Laseroptek Co., Ltd. (199550.KQ)

9,630.00
-430.00
(-4.27%)
At close: May 9 at 3:30:05 PM GMT+9
Loading Chart for 199550.KQ
  • Previous Close 10,060.00
  • Open 10,060.00
  • Bid 9,590.00 x --
  • Ask 9,620.00 x --
  • Day's Range 9,570.00 - 10,070.00
  • 52 Week Range 4,660.00 - 12,550.00
  • Volume 262,190
  • Avg. Volume 2,474,247
  • Market Cap (intraday) 112.242B
  • Beta (5Y Monthly) -0.60
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Laseroptek Co., Ltd. develops and manufactures aesthetic and medical laser devices in South Korea. Its laser devices perform aesthetic and medical dermatological treatments for a range of indications, such as benign pigmentation lesions, fine lines and wrinkles, scar revision, skin rejuvenation and lifting, hair removal, vascular lesions, vitiligo, psoriasis, atopic dermatitis, leukoderma, and alopecia areata. The company was founded in 2000 and is based in Seongnam-si, South Korea.

www.laseroptek.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 199550.KQ

View More

Performance Overview: 199550.KQ

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

199550.KQ
81.02%
KOSPI Composite Index (^KS11)
7.41%

1-Year Return

199550.KQ
6.23%
KOSPI Composite Index (^KS11)
4.97%

3-Year Return

199550.KQ
5.45%
KOSPI Composite Index (^KS11)
2.54%

5-Year Return

199550.KQ
5.45%
KOSPI Composite Index (^KS11)
32.45%

Compare To: 199550.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 199550.KQ

View More

Valuation Measures

As of 5/9/2025
  • Market Cap

    112.24B

  • Enterprise Value

    112.64B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.40

  • Price/Book (mrq)

    3.68

  • Enterprise Value/Revenue

    3.41

  • Enterprise Value/EBITDA

    56.20

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.37%

  • Return on Assets (ttm)

    -0.33%

  • Return on Equity (ttm)

    -3.10%

  • Revenue (ttm)

    33.04B

  • Net Income Avi to Common (ttm)

    -783.26M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.23B

  • Total Debt/Equity (mrq)

    37.26%

  • Levered Free Cash Flow (ttm)

    -5.78B

Research Analysis: 199550.KQ

View More